SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001096906-24-000515
Filing Date
2024-03-19
Accepted
2024-03-19 19:24:23
Documents
1
Period of Report
2024-03-15

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT form4.html 4  
1 PRIMARY DOCUMENT form4.xml 4 4055
  Complete submission text file 0001096906-24-000515.txt   5658
Mailing Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121
Business Address 6191 CORNERSTONE COURT, E SUITE 114 SAN DIEGO CA 92121 (212) 751-0001
AXIM BIOTECHNOLOGIES, INC. (Issuer) CIK: 0001514946 (see all company filings)

IRS No.: 274092986 | State of Incorp.: NV | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O NORTHVIEW ACQUISITION CORP. 207 WEST 25TH STREET, 9TH FLOOR NEW YORK NY 10001
Business Address
O'Rourke Peter (Reporting) CIK: 0001890749 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-54296 | Film No.: 24765736